FDA approved, compounded, and unapproved are not synonyms
A plain-language map of product categories that are often blurred in peptide discussions.
Educational information only — not medical advice. This material cannot diagnose a condition, recommend treatment, or replace care from a qualified clinician who knows your history. The Peptide Center uses an evidence-first editorial process that prioritizes primary regulatory sources, trial registries, and peer-reviewed research; uncertainty and evidence limits should be part of every health claim.
FDA approval applies to a specific complete product for defined uses after agency review. A compounded drug may be prepared for an individual patient under applicable law, but it is not FDA approved. An unapproved product has not received FDA approval. Evidence and labeling for an approved product should not be attributed to a compounded or unapproved version. Read the FDA safety information on unapproved GLP-1 products.
References
Related resources
Continue with curated, same-topic resources from the published library. These links are educational references, not treatment recommendations.
An ingredient name is not a complete product
Why matching a molecule name does not establish sameness in approval, formulation, quality, or evidence.
Open resourceArticleCompounded is not the same as generic
A plain-language explanation of two categories that are often incorrectly treated as interchangeable.
Open resource